Cargando…

Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants

Background: Azvudine (FNC) is a promising treatment candidate for managing coronavirus disease 2019 (COVID-19). However, drug interactions with azvudine have been poorly studied, especially with no reported cases of azvudine with anticoagulants such as warfarin and rivaroxaban. Case summary: The pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xi, Jiao, Fengwei, Li, Guangrun, Yu, Xiaojia, Pei, Yuqing, Zhang, Ying, Wang, Zihui, Li, Pengfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235595/ https://www.ncbi.nlm.nih.gov/pubmed/37274098 http://dx.doi.org/10.3389/fphar.2023.1191608

Ejemplares similares

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials
por: Zhu, Ke-Wei
Publicado: (2023)

Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching
por: Wei, An-Hua, et al.
Publicado: (2023)

A case of successful concomitant administration of warfarin and uracil‐tegafur/leucovorin achieved by self‐measurement of INR
por: Watanabe, Norio, et al.
Publicado: (2017)

A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients
por: Sølbeck, Sacha, et al.
Publicado: (2012)

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
por: Ferrazzi, Paola, et al.
Publicado: (2010)

Antiviral effect of azvudine and nirmatrelvir-ritonavir among hospitalized patients with COVID-19
por: Gao, Yuan, et al.
Publicado: (2023)

Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases
por: Yetkin, Ufuk, et al.
Publicado: (2004)

Warfarin/herbal drink interaction: Elevated INR: case report
Publicado: (2021)

Analysis of Factors That Interrupt With INR Control in the First Anticoagulation Clinic Monitoring Jordanian Patients
por: Al-Momany, Nairooz H., et al.
Publicado: (2019)

Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic
por: Papala, Michelle, et al.
Publicado: (2021)

INR reduction after prothrombin complex concentrate (Co-fact(©)) administration: comparison of INR outcomes in different patient categories at the emergency department
por: Roodheuvel, Floris, et al.
Publicado: (2013)

Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
por: Kim, Esther, et al.
Publicado: (2016)

Multiple drugs: Elevated INR and off-label use: case report
Publicado: (2022)

INR Goal Attainment and Oral Anticoagulation Knowledge of Patients Enrolled in an Anticoagulation Clinic in a Veterans Affairs Medical Center
por: Ryals, Casey A., et al.
Publicado: (2011)

Azvudine (FNC): a promising clinical candidate for COVID-19 treatment
por: Yu, Bin, et al.
Publicado: (2020)

The first Chinese oral anti-COVID-19 drug Azvudine launched
por: Yu, Bin, et al.
Publicado: (2022)

Joint population pharmacokinetic modeling of venlafaxine and O-desmethyl venlafaxine in healthy volunteers and patients to evaluate the impact of morbidity and concomitant medication
por: Wang, Zhanzhang, et al.
Publicado: (2022)

Atomkärnans inre omprövas
por: Kullander, Sven
Publicado: (1986)

Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study
por: Zong, Kaican, et al.
Publicado: (2023)

Pharmacy Technician Management of Stable, In-Range INRs Within a Clinical Pharmacy Anticoagulation Service
por: Hawkins, Kelsey L., et al.
Publicado: (2018)

Efficacy of Nirmatrelvir-Ritonavir versus Azvudine for COVID-19 Treatment in Tibet: A Retrospective Study
por: Zhao, Xiang, et al.
Publicado: (2023)

Out‐of‐range INR results lead to increased health‐care utilization in four large anticoagulation clinics
por: Barnes, Geoffrey D, et al.
Publicado: (2018)

Enoxaparin-sodium/heparin/warfarin: Heparin-induced thrombocytopenia and elevated INR: case report
Publicado: (2021)

Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
por: Zhang, Jin-Lan, et al.
Publicado: (2021)

Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis
por: Chen, Zhaoyan, et al.
Publicado: (2023)

Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with Azvudine
por: Mao, Manyun, et al.
Publicado: (2023)

Peripheral Neuropathy During Concomitant Administration of Proteasome Inhibitors and Factor Xa Inhibitors: Identifying the Likelihood of Drug-Drug Interactions
por: Meng, Long, et al.
Publicado: (2022)

Security and cost comparison of INR self-testing and conventional hospital INR testing in patients with mechanical heart valve replacement
por: Chen, Qiu-lin, et al.
Publicado: (2015)

Pharmacokinetic study of single and multiple oral administration of glutamine in healthy Beagles
por: Guo, Fanxi, et al.
Publicado: (2022)

Effects of Oral Ginger Supplementation on the INR
por: Rubin, Daniel, et al.
Publicado: (2019)

Is Azvudine Comparable to Nirmatrelvir-Ritonavir in Real-World Efficacy and Safety for Hospitalized Patients with COVID-19? A Retrospective Cohort Study
por: Zhao, Qinqin, et al.
Publicado: (2023)

Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
por: Dian, Yating, et al.
Publicado: (2023)

Does prophylactic antibiotic administration for tooth extraction affect PT-INR in patients taking warfarin?
por: Iwata, Eiji, et al.
Publicado: (2020)

Study and exploration of the pharmacokinetics of traditional Tibetan medicine Ruyi Zhenbao tablets after single and long-term administration
por: Hou, Hongping, et al.
Publicado: (2022)

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)
por: Smith, Danielle E, et al.
Publicado: (2010)

Relationship between the Occurrence of Thromboembolism and INR Measurement Interval in Low Intensity Anticoagulation after Aortic Mechanical Valve Replacement
por: Rhie, Sangho, et al.
Publicado: (2011)

Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding
por: Nagata, Naoyoshi, et al.
Publicado: (2017)

Comparison of the effects of different treatment protocols on mortality in patients presenting with an INR≥10 due to warfarin-associated over-anticoagulation
por: İslam, Mehmet Muzaffer, et al.
Publicado: (2023)

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration
por: Din, Natasha, et al.
Publicado: (2023)

Metal specificity of cyanobacterial nickel-responsive repressor InrS: cells maintain zinc and copper below the detection threshold for InrS
por: Foster, Andrew W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_15gah648sa56u6o5sh4t6shmau